Abstract
853P - ARCHES - The role of androgen deprivation therapy (ADT) with enzalutamide (ENZA) or placebo (PBO) in metastatic hormone-sensitive prostate cancer (mHSPC): Post hoc analyses of high and low disease volume and risk groups
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have